investor login
contact
team
dedicated funds
news
portfolio
Portfolio Company News
Search for:
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
Portfolio Company News
Standard Bariatrics Secures $35M in Series B Funding to Accelerate Development and Commercialization of Their First Bariatric Surgical Platform for Sleeve Gastrectomy
Portfolio Company News
CROs dMed and Clinipace Merge to Accelerate Customer Success
Portfolio Company News
Artizan Biosciences Closes $11 Million Series A-2 Financing and Enters Option and License Agreement with Biohaven Therapeutics
Portfolio Company News
FDA approves G1 Therapeutics’ COSELA™ (TRILACICLIB): The first and only myeloprotection therapy to decrease the incidence of chemotherapy-induced myelosuppression
Portfolio Company News
Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists
Portfolio Company News
BIAL Goes Global with New US Research Center and Acquisition of Promising Parkinson’s Disease Programs
Portfolio Company News
Kymera Therapeutics Announces Pricing of Upsized Initial Public Offering
Portfolio Company News
Trefoil Therapeutics Begins First Clinical Trial of Regenerative Treatment for Patients with Corneal Endothelial Dystrophies
Portfolio Company News
Atsena Therapeutics acquires exclusive rights to Gene Therapy for GUCY2D-associated Leber Congenital Amaurosis
Portfolio Company News
Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Patients
Portfolio Company News
Shattuck Labs Announces Closing of $118 Million Series B Financing
Portfolio Company News
Older Posts >
< Newer Posts
contact
team
dedicated funds
news
home
portfolio
